Related Experiment Video

Updated: Jun 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway

Wei Zhu1, Afu Fu, Jia Hu

  • 1State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.

Experimental & Molecular Medicine
|February 8, 2011
PubMed

Insights

5-formylhonokiol (FH) effectively inhibits angiogenesis by suppressing endothelial cell migration and tube formation. This compound targets the extracellular signal-regulated kinase (ERK) pathway, showing potential as an anti-cancer therapeutic.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Honokiol (HK) derivatives, such as 5-formylhonokiol (FH), exhibit enhanced anti-proliferative effects compared to HK.
  • Angiogenesis is a critical process in tumor growth and metastasis.

Purpose of the Study:

  • To investigate the anti-angiogenic potential of 5-formylhonokiol (FH) in vitro and in vivo.
  • To elucidate the molecular mechanisms underlying FH's anti-angiogenic activity.

Main Methods:

  • In vitro assays: HUVEC proliferation, migration (wound-healing), invasion (transwell), and tube formation.
  • In vivo model: Zebrafish angiogenesis.
  • Molecular analysis: Western blotting to assess ERK and Akt signaling pathways.

Main Results:

  • FH significantly inhibited HUVEC migration, invasion, and tube formation in a dose-dependent manner.
  • FH suppressed angiogenesis in the zebrafish model.
  • FH down-regulated ERK expression and phosphorylation, suggesting ERK pathway inhibition.

Conclusions:

  • 5-formylhonokiol (FH) demonstrates potent anti-angiogenic properties.
  • FH exerts its effects partly by inhibiting the ERK signaling pathway.
  • FH is a promising candidate for anti-angiogenesis and anti-cancer therapies.

More Related Videos

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis06:12

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...